First-in-class drug discovery
Novel Targets in the Nuclear Receptor Family
Orphagen Pharmaceuticals addresses the pharmaceutical industry’s need for new classes of drugs that have novel therapeutic mechanisms. We recognize that patients need genuinely new therapies rather than incremental improvements over existing ones.
We focus on the unexplored or “orphan” members of the nuclear receptor family, a highly successful target class.